{
    "type": "bundle",
    "id": "bundle--16dcc6c8-57f7-49c0-8dd5-0cc8d98fb3d2",
    "spec_version": "2.0",
    "objects": [
        {
            "created_by_ref": "identity--c78cb6e5-0c4b-4611-8297-d1b8b55e40b5",
            "object_marking_refs": [
                "marking-definition--fa42a846-8d90-4e51-bc29-71d5b4802168"
            ],
            "source_ref": "intrusion-set--899ce53f-13a0-479b-a0e4-67d46e241542",
            "target_ref": "malware--959f3b19-2dc8-48d5-8942-c66813a5101a",
            "external_references": [
                {
                    "source_name": "CISA WellMail July 2020",
                    "url": "https://us-cert.cisa.gov/ncas/analysis-reports/ar20-198c",
                    "description": "CISA. (2020, July 16). MAR-10296782-3.v1 \u2013 WELLMAIL. Retrieved September 29, 2020."
                },
                {
                    "source_name": "NCSC APT29 July 2020",
                    "url": "https://www.ncsc.gov.uk/files/Advisory-APT29-targets-COVID-19-vaccine-development-V1-1.pdf",
                    "description": "National Cyber Security Centre. (2020, July 16). Advisory: APT29 targets COVID-19 vaccine development. Retrieved September 29, 2020."
                }
            ],
            "description": "(Citation: CISA WellMail July 2020)(Citation: NCSC APT29 July 2020)",
            "relationship_type": "uses",
            "id": "relationship--0465916e-9561-4518-b2fa-09be21bc04e1",
            "type": "relationship",
            "modified": "2020-09-29T18:41:32.760Z",
            "created": "2020-09-29T18:40:02.430Z"
        }
    ]
}